Article Text

other Versions

PDF
Recent advances in the management of cystic fibrosis
  1. Jane C Davies1,2,
  2. Anne-Marie Ebdon2,
  3. Christopher Orchard3
  1. 1Imperial College, London, UK
  2. 2Royal Brompton and Harefield NHS Foundation Trust, London, UK
  3. 3Frimley Park Hospital, Frimley, Surrey, UK
  1. Correspondence to Professor Jane Davies, Imperial College, London, UK; Royal Brompton and Harefield NHS Foundation Trust, London SW3 6LR, UK; j.c.davies{at}imperial.ac.uk

Abstract

Cystic fibrosis is a disease that still causes a reduced life expectancy. The treatment burden remains high for affected individuals with often a combination of multiple oral and inhaled medications, as well as physiotherapy, required on a daily basis. In this article, we look at an overview of the pathogenesis, how this might lead to treatment options and look at some of the available new therapies, all in the aim of increasing life expectancy and reducing treatment burden.

  • Cystic Fibrosis
  • Therapeutics

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Atoms
    R Mark Beattie